Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings

被引:2
作者
Shustik, David A. [1 ]
Ng, David C. E. [2 ]
Sittampalam, Kesavan [1 ]
机构
[1] Singapore Gen Hosp, Dept Pathol, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Nucl Med & PET, Singapore 169856, Singapore
关键词
Phosphaturic mesenchymal tumour; oncogenic osteomalacia; tumour induced osteomalacia; phosphaturia; matrix-producing tumours; GROWTH-FACTOR; 23; ONCOGENIC OSTEOMALACIA; DIAGNOSIS; FGF23; FIBROBLAST-GROWTH-FACTOR-23; BONE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phosphaturic mesenchymal tumour mixed connective tissue variant (PMTMCT) is a rare tumour occurring in bone and soft tissue that usually behaves in a benign manner. Elaboration of biologically active substances by this tumour gives rise to a paraneoplastic syndrome known as oncogenic osteomalacia, manifesting clinically as bone pain, generalized weakness and pathological fractures. Recognition of PMTMCT and its associated syndrome is important, as resection of the tumour in most instances results in prompt resolution of symptoms. Previously reported cases of this tumour have emphasized the consistent presence of certain histological features that are considered prerequisite for making the diagnosis of PMTMCT. We describe three cases of PMTMCT, of which two first presented with progressive symptoms of osteomalacia and one remained clinically silent aside from the symptom of a palpable lump. Our cases highlight the wide-ranging histological patterns displayed by these tumours, and draw attention to certain microscopic findings that until now have been given little if any mention. Tentacular growth pattern and satellite nodules appear to be common findings in PMTMCTs, and can make complete surgical excision of these tumours challenging. The ability of this otherwise histologically benign tumour to permeate vascular spaces has to our knowledge never been described previously. One tumour lacked the characteristic calcifying matrix of PMTMCT, suggesting that in some tumours this defining feature may be focal if not entirely absent. PMTMCT shares features with and can resemble a variety of bone and soft tissue neoplasms, requiring the surgical pathologist to be familiar with this entity.
引用
收藏
页码:7506 / 7517
页数:12
相关论文
共 28 条
[1]   RT-PCR Analysis for FGF23 Using Paraffin Sections in the Diagnosis of Phosphaturic Mesenchymal Tumors With and Without Known Tumor Induced Osteomalacia [J].
Bahrami, Armita ;
Weiss, Sharon W. ;
Montgomery, Elizabeth ;
Horvai, Andrew E. ;
Jin, Long ;
Inwards, Carrie Y. ;
Folpe, Andrew L. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (09) :1348-1354
[2]   Case 33-2011: A 56-Year-Old Man with Hypophosphatemia [J].
Bergwitz, Clemens ;
Collins, Michael T. ;
Kamath, Ravi S. ;
Rosenberg, Andrew E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (17) :1625-1635
[3]   Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour [J].
Clugston, Ellery ;
Gill, Anna C. ;
Graf, Nicole ;
Bonar, Fiona ;
Gill, Anthony J. .
PATHOLOGY, 2015, 47 (02) :173-175
[4]  
de Beur SMJ, 2005, JAMA-J AM MED ASSOC, V294, P1260
[5]   Oncogenic osteomalacia:: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case [J].
Dupond, JL ;
Mahammedi, H ;
Prié, D ;
Collin, F ;
Gil, H ;
Blagosklonov, O ;
Ricbourg, B ;
Meaux-Ruault, N ;
Kantelip, B .
BONE, 2005, 36 (03) :375-378
[6]   Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity - An analysis of 32 cases and a comprehensive review of the literature [J].
Folpe, AL ;
Fanburg-Smith, JC ;
Billings, SD ;
Bisceglia, M ;
Bertoni, F ;
Cho, JY ;
Econs, MJ ;
Inwards, CY ;
de Beur, SMJ ;
Mentzel, T ;
Montgomery, E ;
Michal, M ;
Miettinen, M ;
Mills, SE ;
Reith, JD ;
O'Connell, JX ;
Rosenberg, AE ;
Rubin, BP ;
Sweet, DE ;
Vinh, TN ;
Wold, LE ;
Wehrli, BM ;
White, FKE ;
Zaino, RJ ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) :1-30
[7]   Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas [J].
Graham, Rondell ;
Krishnamurthy, Smita ;
Oliveira, Andre ;
Inwards, Carrie ;
Folpe, Andrew L. .
JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (10) :907-909
[8]   Oncogenic hypophosphataemic osteomalacia:: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1 [J].
Hannan, Fadil M. ;
Athanasoul, Nicholas A. ;
Teh, James ;
Gibbons, Christopher L. M. H. ;
Shine, Brian ;
Thakker, Rajesh V. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (02) :265-271
[9]   Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A) [J].
Houang, Michelle ;
Clarkson, Adele ;
Sioson, Loretta ;
Elston, Marianne S. ;
Clifton-Bligh, Roderick J. ;
Dray, Michael ;
Ranchere-Vince, Dominique ;
Decouvelaere, Anne-Valerie ;
de la Fouchardiere, Arnaud ;
Gill, Anthony J. .
HUMAN PATHOLOGY, 2013, 44 (12) :2711-2718
[10]  
Hu Fang-Ke, 2011, Chin J Cancer, V30, P794, DOI 10.5732/cjc.011.10013